Why Is BADGER METER INC (BMI) Stock Down Today?

Badger Meter (BMI) shares fell 6.94% to $145.13, reversing a recent upward trend. The primary driver appears to be a divergence in analyst sentiment, as Northcoast downgraded the stock to Neutral while Argus Research upgraded it to Buy.

What Happened

Northcoast downgraded Badger Meter to Neutral from Buy, a move that coincided with the sharp intraday decline. In contrast, Argus Research upgraded the stock to Buy on October 23, 2026, and set a price target of $170. RBC Capital also maintained an Outperform rating and raised its price target to $187 following upbeat third-quarter earnings. The conflicting signals from analysts created a volatile environment for the stock.

What The Data Shows

The stock opened at $154.81, a 0.7% gap down from the prior close of $155.95. It reached a session high of $157.16 at 9:30 AM ET before dropping to a session low of $145.13 at 10:10 AM ET. Volume stood at 0.1 million shares, which is 0.1 times the three-month daily average. Fundamentals show a market cap of $4.3 billion, a P/E ratio of 36.0, and a net margin of 14.4%. The stock has a beta of 0.64 and a dividend yield of 1.16%. Over the last 52 weeks, the stock traded between $112.09 and $192.28. In the last eight sessions, the stock moved up 23.3%, rising from $126.43 to $155.95. On October 27, 2026, the stock printed one fresh 52-week high and 22 fresh 52-week lows. Edward F. Callahan, VP of Engineering, bought shares on July 30, 2026. Donald J. Trump disclosed buying $15,001 to $50,000 on August 31, 2026, and selling $50,001 to $100,000 on July 29, 2026.

What To Watch

Investors should monitor the broader analyst coverage, particularly how the market digests the conflicting ratings from Northcoast and Argus Research. The upcoming earnings date is not specified in the provided data, so attention will likely remain on the stock's ability to stabilize after the recent 23.3% rally.